A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma

Mise à jour : Il y a 4 ans
Référence : NCT00044512

Femme et Homme

Extrait

Evaluate anti-cancer activity (e.g. proportion of patients with confirmed complete response or partial response) in patients with advanced, inoperable biopsy-proven hepatocellular carcinoma.


Critère d'inclusion

  • Carcinoma, hepatocellular


Liens